FDA 510(k) Search - By Innolitics (SaMD and AI Experts)

The EAA™ is a rapid in vitro diagnostic test that utilizes a specific monoclonal antibody to measure the endotoxin activity in EDTA whole blood specimens. The information, when used in conjunction with other clinical information and other relevant diagnostic tests aids in the risk assessment of patients in the ICU for progression to severe sepsis. Patients tested on their first day of admission to the ICU where the endotoxin activity (EA) value is ≥ 0.60, are three times more likely to develop severe sepsis within the next three days than subjects whose EA values are

Device Description

Not Found

AI/ML Overview

The provided text is a 510(k) clearance letter for the Endotoxin Activity Assay (EAA) device. It does not contain information about acceptance criteria, study details, or performance data of the device. The document primarily focuses on the regulatory clearance process, the device's intended use, and general FDA regulations.

Therefore, I cannot provide the requested information based on the given text. A typical 510(k) submission summary or a separate clinical study report would be required to answer these questions.

Ask a Question

Ask a specific question about this device

K Number

DEN030002

Device Name

ENDOTOXIN ACTIVITY ASSAY (EAA) DEVICE

Manufacturer

SPECTRAL DIAGNOSTICS, INC.

Date Cleared

2003-06-16

(63 days)

Product Code